.png){kind=small}
.png){kind=small}
BackTable / Urology / Podcast / Episode #206
Biochemical Recurrence: Insights from AUA/ASTRO/SUO Guidelines
with Dr. Todd Morgan
Have you checked out the AUA/ASTRO/SUO’s recently released guidelines for salvage therapy in prostate cancer biochemical recurrence? In this episode of the BackTable Urology Podcast, guest Dr. Todd Morgan from the University of Michigan and host Dr. Aditya Bagrodia continue with part two of our series on prostate cancer biochemical recurrence management.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2024, December 17). Ep. 206 – Biochemical Recurrence: Insights from AUA/ASTRO/SUO Guidelines [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Todd Morgan
Dr. Todd Morgan is the chief of urologic oncology at the University of Michigan.
Dr. Aditya Bagrodia
Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.
Synopsis
The doctors focus on the difficulty in declaring a patient 'cured' and the implications of biochemical recurrence after treatment. Dr. Morgan highlights the importance of PSA in the postoperative setting and explores the role of the Decipher Prostate Genomic Classifier in personalizing treatment. He talks through the latest AUA/ASTRO/SUO consensus on biochemical recurrence guidelines, including the significance of early salvage therapy and the integration of advanced imaging techniques like PSMA PET scans. Further, Dr. Morgan emphasizes the role for multidisciplinary evaluation, patient counseling, and future directions of research to refine treatment options.
This discussion underscores the transition from adjuvant to early salvage radiation as a standard practice and considers emerging biomarker strategies to inform treatment decisions.
Timestamps
00:00 - Introduction
03:41 - Consensus Biochemical Recurrence Guidelines
08:56 - Evolution of Post-Prostatectomy Biochemical Recurrence Management
13:24 - Patient Counseling and Risk of Recurrence
17:42 - PSMA PET Scans
20:44 - Postoperative PSA Monitoring
28:35 - The Role of Radiation
31:56 - Hormone Therapy
39:00 - Salvage Lymphadenectomy
46:30 - Future Directions and Concluding Thoughts
Resources
Veracyte
https://www.veracyte.com/
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline (2024)
https://www.auanet.org/guidelines-and-quality/guidelines/salvage-therapy-for-prostate-cancer
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
